In order to verify this signal pathway, specific ERK inhibitor U0126 was used to block the pathway, and observed the spontaneous activities and the change of the key molecular effects of the signaling pathway in CRS model group. The gene discussed is MAPK1; the disease is congenital rubella syndrome.